Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
DNA	GINKGO BIOWORKS HOLDINGS INC	$6.96	-5.56%	-11.56%	22.97%	-45.84%	-10.19%	-79.34%	-94.44%	N/A	N/A	$41.20	$5.00	83.11%	39.20%	2.37	955,817	-22.74%
ROIV	ROIVANT SCIENCES LTD	$11.58	-0.34%	5.27%	17.56%	8.22%	-0.86%	3.30%	200.78%	N/A	N/A	$13.06	$8.73	11.30%	32.65%	0.84	8,592,628	24.87%
IONS	IONIS PHARMACEUTICALS INC	$31.71	3.26%	7.24%	16.32%	-1.31%	-18.19%	-26.27%	-17.36%	-42.68%	-45.55%	$52.34	$23.95	39.42%	32.40%	0.83	2,691,060	12.27%
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	$1.99	-3.86%	3.11%	-0.50%	-37.22%	-50.50%	-56.50%	-89.36%	-94.31%	N/A	$6.90	$1.69	71.16%	17.75%	0.39	17,267	15.96%
VYNE	VYNE THERAPEUTICS INC	$1.34	0.75%	-28.72%	-12.42%	-42.24%	-49.43%	-47.04%	-82.06%	-98.95%	N/A	$4.30	$1.27	68.84%	5.51%	1.12	96,841	-75.52%
ELAB	PMGC HOLDINGS INC	$2.39	4.37%	7.66%	-44.80%	-80.26%	-94.09%	-99.74%	N/A	N/A	N/A	$1.01k	$2.14	99.76%	11.68%	1.02	108,912	-23.59%
ATNM	ACTINIUM PHARMACEUTICALS INC	$1.49	-1.97%	17.32%	0.00%	26.27%	-12.87%	-80.85%	-75.37%	-72.16%	-98.03%	$10.24	$1.03	85.45%	44.80%	1.12	317,964	-39.90%
SVRA	SAVARA INC	$3.26	1.88%	-0.31%	13.99%	16.43%	-9.44%	-34.14%	176.27%	41.74%	N/A	$5.31	$2.26	38.61%	44.57%	0.89	903,820	138.77%
OSTX	OS THERAPIES INC	$1.93	-4.93%	19.88%	45.11%	10.29%	-26.62%	N/A	N/A	N/A	N/A	$7.00	$1.12	72.43%	72.32%	0.95	364,456	10.49%
AMLX	AMYLYX PHARMACEUTICALS INC	$5.14	0.59%	-1.91%	53.89%	50.29%	-8.87%	166.32%	-43.70%	N/A	N/A	$7.27	$1.58	29.30%	226.35%	1.20	1,474,211	41.45%
CRVS	CORVUS PHARMACEUTICALS INC	$3.52	-1.95%	-3.83%	11.04%	-30.57%	-61.32%	118.63%	158.82%	63.72%	N/A	$10.00	$1.43	64.80%	146.15%	1.04	637,853	32.54%
EWTX	EDGEWISE THERAPEUTICS INC	$16.68	1.71%	8.31%	-17.14%	-40.85%	-50.94%	-12.26%	100.24%	N/A	N/A	$38.12	$10.60	56.24%	57.36%	1.39	1,089,429	-10.85%
VERU	VERU INC	$0.52	-3.32%	-4.55%	-18.13%	-12.08%	-31.32%	-64.83%	-94.90%	-83.78%	-82.30%	$1.75	$0.45	70.06%	16.44%	1.01	701,844	-25.49%
RVPH	REVIVA PHARMACEUTICALS HOLDINGS INC	$0.87	-1.91%	-3.00%	40.58%	-56.13%	-10.74%	-73.22%	-54.77%	-91.77%	N/A	$4.28	$0.49	79.60%	80.00%	0.60	316,837	24.56%
GPCR	STRUCTURE THERAPEUTICS INC	$27.33	1.22%	15.56%	73.08%	-3.60%	-33.57%	-30.49%	N/A	N/A	N/A	$62.74	$13.22	56.44%	106.73%	0.96	656,191	-56.22%
HUMA	HUMACYTE INC	$1.41	-2.76%	-4.73%	-5.37%	-67.21%	-73.84%	-67.95%	-80.76%	N/A	N/A	$9.97	$1.15	85.86%	22.61%	1.40	1,316,983	-6.63%
BTAI	BIOXCEL THERAPEUTICS INC	$1.78	-4.05%	-4.05%	-7.55%	-63.94%	-82.75%	-95.63%	-99.20%	-99.68%	N/A	$42.72	$1.29	95.85%	37.60%	1.55	69,615	-17.59%
RCUS	ARCUS BIOSCIENCES INC	$8.62	-1.49%	2.50%	11.80%	-34.70%	-44.39%	-44.39%	-65.97%	-67.12%	N/A	$18.98	$6.50	54.58%	32.62%	1.43	846,395	-44.08%
CNTA	CENTESSA PHARMACEUTICALS PLC	$13.50	-1.53%	-0.81%	2.04%	-20.12%	-13.85%	42.41%	55.53%	N/A	N/A	$19.09	$7.75	29.28%	74.19%	1.00	608,408	9.90%
MNMD	MIND MEDICINE (MINDMED) INC	$6.59	3.13%	2.49%	18.95%	-10.58%	7.33%	-30.12%	-47.85%	2.17%	N/A	$10.44	$4.70	36.85%	40.21%	1.69	694,462	-63.50%
RPTX	REPARE THERAPEUTICS INC	$1.41	2.92%	6.02%	38.24%	15.57%	-60.61%	-57.27%	-87.79%	N/A	N/A	$4.29	$0.89	67.13%	58.43%	1.17	473,260	48.66%
MAZE	MAZE THERAPEUTICS INC	$10.59	14.49%	37.53%	6.97%	-29.40%	N/A	N/A	N/A	N/A	N/A	$17.00	$6.71	37.71%	57.82%	0.58	182,743	-77.14%
CERO	CERO THERAPEUTICS HOLDINGS INC	$0.89	0.22%	-19.64%	23.89%	-55.40%	-89.27%	-99.35%	-99.91%	N/A	N/A	$143.00	$0.53	99.38%	67.04%	0.30	397,740	30.30%
FDMT	4D MOLECULAR THERAPEUTICS INC	$3.44	2.08%	5.85%	15.05%	-41.99%	-57.50%	-86.45%	-72.66%	N/A	N/A	$28.93	$2.24	88.11%	53.91%	1.29	560,500	85.58%
AVIR	ATEA PHARMACEUTICALS INC	$2.99	1.36%	4.18%	4.91%	2.40%	-9.12%	-22.34%	-51.30%	N/A	N/A	$4.15	$2.60	27.86%	15.00%	0.95	423,057	-54.32%
AGIO	AGIOS PHARMACEUTICALS INC	$30.94	4.21%	5.74%	12.92%	-7.96%	-31.05%	-8.08%	31.21%	-16.40%	-67.68%	$62.58	$23.42	50.56%	32.14%	1.18	597,409	-12.99%
MRNA	MODERNA INC	$27.03	-5.29%	-1.31%	-0.48%	-26.05%	-50.52%	-75.75%	-80.98%	-43.61%	N/A	$170.47	$23.15	84.14%	16.76%	1.17	14,848,872	92.10%
WINT	WINDTREE THERAPEUTICS INC	$1.00	-14.53%	-14.53%	-16.67%	-84.08%	-97.23%	-99.55%	-100.00%	-100.00%	-100.00%	$737.44	$0.96	99.86%	4.06%	0.74	690,641	578.14%
GHRS	GH RESEARCH PLC	$10.77	12.89%	13.37%	0.09%	-40.13%	32.15%	-9.87%	-26.48%	N/A	N/A	$20.50	$6.00	47.46%	79.50%	0.95	199,485	-12.79%
RCKT	ROCKET PHARMACEUTICALS INC	$7.86	3.01%	5.79%	35.28%	-25.57%	-53.71%	-65.11%	-26.47%	-46.71%	-66.47%	$26.98	$4.55	70.87%	72.75%	1.63	2,851,245	42.70%
ENVB	ENVERIC BIOSCIENCES INC	$1.28	-3.03%	-4.12%	-2.29%	-29.28%	-82.64%	-90.82%	-99.36%	-99.95%	N/A	$15.45	$1.01	91.72%	26.73%	1.58	40,504	-29.05%
SLXN	SILEXION THERAPEUTICS CORP	$1.00	1.52%	7.53%	-3.85%	-36.31%	-54.09%	-99.02%	-98.87%	N/A	N/A	$122.02	$0.58	99.18%	73.91%	0.44	323,066	0.78%
OCGN	OCUGEN INC	$0.74	-1.20%	0.14%	14.06%	2.50%	-22.23%	-46.91%	-68.46%	119.64%	-99.85%	$2.06	$0.52	64.17%	43.30%	1.87	2,646,574	-1.29%
ABCL	ABCELLERA BIOLOGICS INC	$2.49	-4.60%	-4.23%	19.14%	-19.16%	-8.79%	-34.13%	-69.14%	N/A	N/A	$4.34	$1.89	42.63%	31.68%	1.25	3,438,524	27.96%
CVKD	CADRENAL THERAPEUTICS INC	$16.50	0.49%	-2.94%	-5.50%	-16.54%	-6.25%	142.04%	N/A	N/A	N/A	$22.90	$5.70	27.95%	189.47%	0.80	33,480	130.28%
CRGX	CARGO THERAPEUTICS INC	$4.37	-4.38%	-3.43%	6.07%	19.73%	-78.55%	-78.72%	N/A	N/A	N/A	$25.45	$3.00	82.83%	45.67%	1.05	373,622	-70.61%
NUVB	NUVATION BIO INC	$2.27	0.89%	6.57%	29.71%	0.00%	-1.30%	-29.06%	-52.90%	N/A	N/A	$3.97	$1.54	42.82%	47.40%	1.14	2,147,611	-21.39%
PDSB	PDS BIOTECHNOLOGY CORP	$1.33	-5.00%	0.76%	23.15%	-16.35%	-58.44%	-63.16%	-76.91%	46.15%	N/A	$4.42	$0.85	69.91%	56.29%	1.91	87,866	-68.48%
CING	CINGULATE INC	$4.30	2.14%	-0.92%	1.18%	-4.87%	11.69%	-65.54%	-98.77%	N/A	N/A	$20.83	$1.80	79.36%	138.89%	0.99	28,189	-77.34%
GOVX	GEOVAX LABS INC	$0.99	-2.08%	-1.10%	-8.43%	-44.12%	-48.49%	-31.79%	-91.41%	-99.23%	-100.00%	$11.18	$0.73	91.15%	35.48%	1.14	258,824	4.78%
PYXS	PYXIS ONCOLOGY INC	$1.10	0.00%	0.92%	20.22%	-26.67%	-70.74%	-75.00%	-56.86%	N/A	N/A	$5.39	$0.83	79.59%	32.05%	1.05	261,066	-51.30%
KOD	KODIAK SCIENCES INC	$4.49	2.98%	7.16%	75.39%	-22.85%	16.93%	27.20%	-30.28%	-91.18%	N/A	$11.60	$1.92	61.29%	133.85%	1.79	434,821	40.65%
HOTH	HOTH THERAPEUTICS INC	$0.89	-0.67%	3.96%	-8.41%	-26.20%	3.84%	-24.96%	-92.93%	-99.00%	N/A	$3.80	$0.58	76.50%	53.97%	0.73	75,286	-37.94%
ALT	ALTIMMUNE INC	$5.17	-1.52%	0.00%	8.96%	-19.72%	-23.29%	-26.87%	9.53%	74.66%	-98.92%	$11.16	$3.55	53.67%	45.51%	1.14	2,093,025	15.96%
MIST	MILESTONE PHARMACEUTICALS INC	$1.32	0.00%	4.76%	73.68%	-32.65%	-8.33%	-17.50%	-78.54%	-66.75%	N/A	$2.75	$0.63	52.00%	111.20%	0.80	768,985	-69.95%
OTLK	OUTLOOK THERAPEUTICS INC	$1.57	0.00%	1.29%	28.69%	-15.14%	-74.05%	-81.53%	-95.03%	-88.23%	N/A	$9.25	$0.87	83.03%	80.46%	1.14	212,602	-34.94%
SYRE	SPYRE THERAPEUTICS INC	$14.66	-3.74%	-1.81%	-4.15%	-35.98%	-56.86%	-56.72%	-61.42%	-92.18%	N/A	$40.49	$10.91	63.79%	34.37%	1.08	442,147	0.61%
SCPH	SCPHARMACEUTICALS INC	$2.53	-0.78%	1.20%	8.58%	-20.94%	-37.84%	-44.27%	-50.10%	-72.97%	N/A	$5.65	$1.94	55.22%	30.41%	0.93	189,631	-42.23%
OCS	OCULIS HOLDING AG	$17.73	1.90%	-1.77%	-4.98%	-22.44%	-0.84%	37.98%	80.92%	N/A	N/A	$23.08	$10.79	23.18%	64.32%	0.25	63,615	234.69%
GLPG	GALAPAGOS NV	$26.78	-0.52%	1.09%	8.11%	17.35%	-0.41%	-8.73%	-55.34%	-87.50%	N/A	$31.23	$22.36	14.24%	19.77%	0.62	125,733	-74.08%
STTK	SHATTUCK LABS INC	$1.08	9.20%	28.88%	27.66%	-15.95%	-13.60%	-90.06%	-72.59%	N/A	N/A	$11.76	$0.69	90.82%	56.07%	1.25	180,366	-33.74%
TYRA	TYRA BIOSCIENCES INC	$10.48	1.75%	3.87%	20.18%	-24.33%	-36.06%	-42.70%	24.76%	N/A	N/A	$29.60	$6.42	64.59%	63.24%	1.41	316,995	32.93%
CYBN	CYBIN INC	$6.62	-1.49%	-6.23%	12.01%	-32.72%	-33.73%	-50.23%	-69.03%	N/A	N/A	$14.44	$4.81	54.16%	37.63%	0.85	208,490	-28.30%
LTRN	LANTERN PHARMA INC	$3.62	2.84%	0.00%	9.37%	-22.48%	9.37%	-32.84%	-37.26%	N/A	N/A	$7.21	$2.55	49.79%	41.96%	1.15	16,599	-30.03%
NUVL	NUVALENT INC	$76.23	-0.68%	3.04%	12.10%	-10.16%	-14.56%	7.90%	640.10%	N/A	N/A	$113.51	$55.54	32.84%	37.26%	1.51	958,991	58.61%
PROK	PROKIDNEY CORP	$0.85	-3.61%	-13.74%	2.89%	-44.90%	-44.90%	-60.46%	-91.34%	N/A	N/A	$4.44	$0.46	80.77%	85.65%	1.19	466,648	-57.26%
VERA	VERA THERAPEUTICS INC	$23.75	1.63%	1.19%	7.86%	-35.00%	-45.80%	-43.88%	17.92%	N/A	N/A	$51.61	$18.53	53.98%	28.17%	1.12	1,925,097	150.95%
ATXS	ASTRIA THERAPEUTICS INC	$5.16	0.00%	-0.96%	-4.44%	-30.55%	-54.42%	-45.68%	-15.41%	-84.13%	N/A	$12.92	$3.56	60.06%	45.15%	0.95	950,745	163.14%
ENGN	ENGENE HOLDINGS INC	$3.74	-9.66%	-6.50%	-13.63%	-44.10%	-57.93%	-76.46%	-62.49%	N/A	N/A	$16.00	$3.50	76.63%	6.86%	0.09	95,184	295.79%
CRNX	CRINETICS PHARMACEUTICALS INC	$33.52	0.39%	0.39%	9.47%	-13.59%	-40.87%	-25.59%	65.29%	105.39%	N/A	$62.53	$24.10	46.39%	39.09%	1.22	645,771	-2.59%
ONCY	ONCOLYTICS BIOTECH INC	$0.55	-3.68%	-5.66%	4.36%	-20.86%	-53.39%	-50.89%	-60.43%	-63.82%	N/A	$1.53	$0.47	64.05%	17.52%	0.91	258,095	-1.67%
SGMT	SAGIMET BIOSCIENCES INC	$3.93	13.91%	25.96%	52.33%	-15.67%	-26.27%	-4.38%	N/A	N/A	N/A	$7.38	$1.73	46.75%	127.17%	2.15	672,966	56.43%
MURA	MURAL ONCOLOGY PLC	$2.61	-0.76%	-1.14%	110.48%	-28.69%	-24.57%	-30.95%	N/A	N/A	N/A	$4.74	$0.95	44.94%	174.74%	0.87	389,110	10.65%
TRML	TOURMALINE BIO INC	$17.85	3.72%	3.06%	25.35%	14.86%	-32.13%	13.62%	-74.79%	N/A	N/A	$29.79	$11.56	40.08%	54.41%	1.22	295,405	-17.55%
CGEM	CULLINAN THERAPEUTICS INC	$8.52	2.90%	4.67%	13.60%	-15.31%	-46.01%	-69.68%	-19.09%	N/A	N/A	$30.19	$6.85	71.78%	24.38%	1.25	457,132	27.44%
ORKA	ORUKA THERAPEUTICS INC	$10.09	-3.35%	-3.90%	5.54%	-26.35%	-62.89%	-74.13%	-64.52%	-76.18%	-99.21%	$53.88	$5.49	81.27%	83.96%	0.55	126,215	9.52%
REPL	REPLIMUNE GROUP INC	$9.64	-1.43%	6.40%	14.76%	-29.69%	-18.99%	48.77%	-42.69%	-40.53%	N/A	$17.00	$4.92	43.29%	95.93%	1.00	651,530	-26.20%
ACLX	ARCELLX INC	$65.53	0.89%	2.44%	7.96%	1.19%	-23.95%	25.58%	552.04%	N/A	N/A	$107.37	$47.88	38.97%	36.86%	1.03	314,495	2.75%
TERN	TERNS PHARMACEUTICALS INC	$3.56	7.88%	16.72%	39.06%	-18.54%	-48.70%	-29.92%	114.46%	N/A	N/A	$11.40	$1.87	68.77%	90.88%	0.95	1,236,537	20.82%
NMRA	NEUMORA THERAPEUTICS INC	$0.77	-1.15%	2.80%	-15.55%	-58.55%	-93.10%	-91.53%	N/A	N/A	N/A	$17.19	$0.62	95.51%	24.15%	1.29	737,798	-8.31%
DNTH	DIANTHUS THERAPEUTICS INC	$21.70	-0.69%	2.21%	28.94%	-1.68%	-22.53%	-3.68%	-9.58%	-84.64%	N/A	$32.27	$13.37	32.75%	62.36%	0.98	280,459	6.73%
QSI	QUANTUM-SI INC	$1.16	1.75%	-4.92%	-3.33%	-36.26%	51.04%	-35.56%	-74.45%	N/A	N/A	$5.77	$0.61	79.90%	89.54%	1.85	2,086,102	-28.32%
CADL	CANDEL THERAPEUTICS INC	$4.89	-0.41%	-2.20%	-12.21%	-31.61%	-7.39%	-38.72%	27.34%	N/A	N/A	$14.60	$3.79	66.51%	29.19%	1.03	874,670	31.31%
CCCC	C4 THERAPEUTICS INC	$1.63	-0.61%	1.24%	13.59%	-51.49%	-70.94%	-75.08%	-82.60%	N/A	N/A	$7.66	$1.09	78.72%	50.23%	1.88	562,724	10.44%
KALV	KALVISTA PHARMACEUTICALS INC	$13.60	-1.23%	5.59%	21.92%	47.51%	28.18%	11.66%	1.04%	26.75%	-82.08%	$15.50	$7.30	12.26%	86.30%	0.90	611,107	-30.44%
CRDF	CARDIFF ONCOLOGY INC	$2.71	-1.09%	-6.55%	-11.44%	-32.42%	-15.44%	-35.93%	88.19%	135.65%	-99.56%	$5.64	$2.01	51.94%	34.83%	1.36	477,685	-28.66%
HOWL	WEREWOLF THERAPEUTICS INC	$0.87	-3.44%	-2.90%	0.00%	-36.42%	-64.88%	-85.53%	-79.98%	N/A	N/A	$6.34	$0.60	86.26%	46.39%	1.32	274,434	-34.78%
EDIT	EDITAS MEDICINE INC	$1.62	-1.82%	0.62%	43.36%	27.56%	-44.33%	-70.38%	-88.65%	-92.70%	N/A	$6.69	$0.91	75.78%	78.02%	1.98	1,088,433	-27.93%
QURE	UNIQURE NV	$15.00	1.63%	5.19%	51.36%	-4.76%	155.97%	228.23%	-4.88%	-75.22%	-39.00%	$19.18	$3.73	21.79%	302.14%	1.35	1,014,127	-27.98%
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$12.50	-2.42%	-3.03%	32.56%	-20.89%	-30.56%	-55.21%	-41.01%	-69.41%	-69.94%	$45.00	$8.04	72.22%	55.47%	1.71	392,330	33.77%
ELDN	ELEDON PHARMACEUTICALS INC	$3.28	3.80%	-2.38%	1.86%	-26.46%	-38.11%	43.23%	10.44%	-71.53%	-99.80%	$5.54	$2.00	40.79%	64.00%	0.65	113,995	10.60%
ALLR	ALLARITY THERAPEUTICS INC	$1.17	-2.50%	9.35%	28.57%	4.46%	-15.22%	-97.15%	-100.00%	N/A	N/A	$36.90	$0.61	96.83%	90.55%	0.86	575,336	-77.60%
GLSI	GREENWICH LIFESCIENCES INC	$9.98	-1.19%	-4.41%	7.78%	-23.11%	-25.74%	-28.71%	-10.41%	N/A	N/A	$18.75	$8.06	46.77%	23.82%	0.54	23,733	-9.69%
AURA	AURA BIOSCIENCES INC	$6.07	4.12%	9.96%	7.05%	-20.96%	-40.20%	-20.65%	-66.03%	N/A	N/A	$12.38	$4.84	50.96%	25.41%	1.02	163,770	1.65%
GRI	GRI BIO INC	$1.95	7.14%	16.77%	-3.47%	-81.79%	-89.57%	-97.92%	-100.00%	N/A	N/A	$106.04	$1.10	98.16%	77.27%	0.82	185,506	46.07%
OKUR	ONKURE THERAPEUTICS INC	$2.50	0.40%	-5.66%	-41.31%	-57.56%	-84.65%	46.20%	4.17%	N/A	N/A	$19.60	$1.25	87.24%	100.00%	0.73	22,196	-58.77%
CUE	CUE BIOPHARMA INC	$0.75	-0.40%	-12.25%	0.27%	-46.67%	-50.53%	-60.52%	-81.66%	-96.80%	N/A	$2.26	$0.45	66.73%	67.11%	1.33	48,893	-63.28%
SKYE	SKYE BIOSCIENCE INC	$2.03	-6.88%	13.41%	45.00%	-30.12%	-63.49%	-84.13%	N/A	2,155.56%	-49.25%	$13.51	$1.14	84.97%	78.07%	130.46	275,735	-8.79%
PRQR	PROQR THERAPEUTICS NV	$1.72	3.61%	11.69%	33.33%	-23.56%	-53.89%	-14.00%	145.71%	-64.83%	-91.00%	$4.62	$1.07	62.77%	60.75%	0.96	491,688	25.96%
VIGL	VIGIL NEUROSCIENCE INC	$2.56	21.90%	43.02%	52.38%	3.23%	-33.85%	-3.40%	-29.67%	N/A	N/A	$6.06	$1.31	57.76%	95.12%	0.96	492,360	183.68%
PCVX	VAXCYTE INC	$35.24	-1.67%	2.12%	9.34%	-58.45%	-67.15%	-44.69%	40.40%	N/A	N/A	$121.06	$27.66	70.89%	27.40%	0.81	3,842,876	143.80%
SLNO	SOLENO THERAPEUTICS INC	$75.02	0.21%	1.06%	9.90%	54.62%	34.30%	57.80%	2,504.86%	66.71%	-83.36%	$76.56	$36.93	2.01%	103.14%	0.59	558,594	-20.41%
KYMR	KYMERA THERAPEUTICS INC	$34.55	0.82%	2.95%	36.91%	-10.24%	-25.65%	-4.66%	5.56%	N/A	N/A	$53.27	$19.45	35.14%	77.68%	1.62	581,952	32.51%
XBIT	XBIOTECH INC	$2.93	-3.62%	-1.01%	-2.98%	-12.01%	-60.14%	-64.09%	-62.05%	-81.29%	-83.39%	$9.45	$2.65	68.99%	10.57%	1.06	56,638	-43.74%
LXEO	LEXEO THERAPEUTICS INC	$4.71	19.85%	28.34%	50.48%	-15.14%	-40.61%	-61.71%	N/A	N/A	N/A	$19.50	$1.45	75.85%	224.83%	1.87	1,335,051	47.78%
UBX	UNITY BIOTECHNOLOGY INC	$1.10	-2.65%	11.79%	14.58%	-49.31%	-16.03%	-29.49%	-88.17%	-98.29%	N/A	$3.10	$0.85	64.52%	28.96%	1.22	70,892	-42.53%
ELTX	ELICIO THERAPEUTICS INC	$5.02	2.03%	-0.99%	1.41%	-43.72%	9.37%	-43.28%	-62.54%	N/A	N/A	$11.45	$3.34	56.16%	50.21%	1.02	27,125	139.01%
CTXR	CITIUS PHARMACEUTICALS INC	$0.72	-5.62%	-17.39%	-39.83%	-73.16%	-91.95%	-96.02%	-97.00%	-96.68%	N/A	$26.25	$0.68	97.25%	6.49%	0.77	130,736	-25.23%
AGEN	AGENUS INC	$2.86	-1.04%	1.42%	78.75%	-18.52%	-29.38%	-78.43%	-92.63%	-94.19%	-97.91%	$19.69	$1.38	85.47%	107.25%	1.53	395,597	-27.18%
APGE	APOGEE THERAPEUTICS INC	$39.20	-0.13%	5.80%	10.08%	-2.90%	-28.06%	-23.00%	N/A	N/A	N/A	$63.50	$26.20	38.27%	49.62%	1.26	432,048	-11.26%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: B.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 147.93% over the past year, overperforming other biotech stocks by 225 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 400% from Protalix Biotherapeutics's current stock price of $3.00.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 57.69% over the past year, overperforming other biotech stocks by 135 percentage points.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: B.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 76, which is 52 points higher than the biotech industry average of 24.

CPRX passed 25 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 59.67% over the past year, overperforming other biotech stocks by 137 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $33.20, an upside of 36.79% from Catalyst Pharmaceuticals's current stock price of $24.27.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.27%, which is 4 percentage points higher than the biotech industry average of 1.81%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.46%, which is 1 percentage points higher than the biotech industry average of 1.81%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.32%, which is the same as the biotech industry average of 1.81%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.68% in the last day, and up 1.97% over the last week. Arvinas was the among the top losers in the biotechnology industry, dropping -24.84% yesterday.

Arvinas shares are trading lower. The company reported Q1 financial results.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -37.78% in the past year. It has overperformed other stocks in the biotech industry by 39 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -1.35% in the past year. It has overperformed other stocks in the biotech industry by 76 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 6.23% in the past year. It has overperformed other stocks in the biotech industry by 83 percentage points.

Are biotech stocks a good buy now?

54.79% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 102% over the next year.

1.74% of biotech stocks have a Zen Rating of A (Strong Buy), 4.13% of biotech stocks are rated B (Buy), 42.39% are rated C (Hold), 35.87% are rated D (Sell), and 15.87% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -169.39x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.